Daniel L. Gustafson

Also affiliated with University of Colorado Denver, Colorado State University

MedicineBiochemistry, Genetics and Molecular BiologyComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 24 papers. Top paper: “A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695)”.

A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695)

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-2409

N/A

2.8DataRank · unranked

92 citations

Catherine M. Tangen, Siamak Daneshmand, Ajjai Alva, Seth P. Lerner, M. Scott Lucia +12 more

Identification of a Small-Molecule Inhibitor That Disrupts the SIX1/EYA2 Complex, EMT, and Metastasis

Cancer Research(2020)10.1158/0008-5472.can-20-0435

N/A

1.4DataRank · unranked

49 citations

Melanie A. Blevins, Jessica Y. Hsu, Deguang Kong, Matthew D. Galbraith, Andrew Goodspeed +20 more

Long-term Outcomes from a Phase 2 Study of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer (SWOG S1314; NCT02177695)

European Urology(2023)10.1016/j.eururo.2023.06.014

N/A

0.650DataRank · unranked

20 citations

Catherine M. Tangen, Siamak Daneshmand, Ajjai Alva, M. Scott Lucia, David J. McConkey +12 more

Association of molecular subtypes with pathologic response in a phase II study of co-expression extrapolation (COXEN) with neoadjuvant chemotherapy (NAC) for localized, muscle-invasive bladder cancer (SWOG S1314; NCT02177695).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.5028

N/A

0DataRank · unranked

4 citations

David J. McConkey, Catherine M. Tangen, Joshua J. Meeks, Thomas W. Flaig, Xing Hua +11 more

Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic Osteosarcoma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2105

N/A

0DataRank · unranked

84 citations

Lyndah Chow, Sunetra Das, Laurel A. Haines, Eric P. Palmer, Jade Kurihara +6 more

Characterizing the molecular and immune landscape of canine bladder cancer

Veterinary and Comparative Oncology(2021)10.1111/vco.12740

N/A

0DataRank · unranked

66 citations

Sunetra Das, Belén Hernández, Daniel P. Regan, Deanna D. Dailey, Robert I. McGeachan +5 more

Cannabidiol Induces Apoptosis and Perturbs Mitochondrial Function in Human and Canine Glioma Cells

Frontiers in Pharmacology(2021)10.3389/fphar.2021.725136

N/A

0DataRank · unranked

57 citations

Dominique Ramirez, Stephanie McGrath, Daniel L. Gustafson, Chase Gross

Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0315

N/A

0DataRank · unranked

55 citations

Christina Mazcko, Aswini Cherukuri, Erika P. Berger, William C. Kisseberth, Megan E. Brown +39 more

Immune pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma

Communications Biology(2021)10.1038/s42003-021-02683-0

N/A

0DataRank · unranked

29 citations

Rupa Idate, Daniel P. Regan, Jared S. Fowles, Susan E. Lana, Douglas H. Thamm +3 more

Pharmacokinetic and Pharmacodynamic Assessment of Hydroxychloroquine in Breast Cancer

Journal of Pharmacology and Experimental Therapeutics(2021)10.1124/jpet.121.000730

N/A

0DataRank · unranked

13 citations

Daniel L. Gustafson, Kristen M. Van Eaton

Evaluation of Intra-Articular Amikacin Administration in an Equine Non-inflammatory Joint Model to Identify Effective Bactericidal Concentrations While Minimizing Cytotoxicity

Frontiers in Veterinary Science(2021)10.3389/fvets.2021.676774

N/A

0DataRank · unranked

12 citations

Lyndah Chow, Dean A. Hendrickson, Daniel L. Gustafson, Andrew Moore, Jason W. Stoneback +7 more

Brief Report: Case Comparison of Therapy With the Histone Deacetylase Inhibitor Vorinostat in a Neonatal Calf Model of Pulmonary Hypertension

Frontiers in Physiology(2021)10.3389/fphys.2021.712583

N/A

0DataRank · unranked

7 citations

Greta M. Krafsur, June A. Boon, Hui Zhang, Min Li, Timothy N. Holt +8 more

Whole exome sequencing and gene expression analysis of canine osteosarcomas identify mutant TP53 and enriched immune pathways associated with longer survival

Research Square(2021)10.21203/rs.3.rs-135094/v1

N/A

0DataRank · unranked

0 citations

Rupa Idate, Daniel P. Regan, Jared S. Fowles, Susan E. Lana, Douglas H. Thamm +3 more

A pilot clinical trial of genomic-based therapy assignment with co-expression extrapolation (COXEN) in advanced/metastatic urothelial carcinoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.452

N/A

0DataRank · unranked

0 citations

Rosa Maria Nadal, Lisa M. Cordes, Seth M. Steinberg, Nicole N. Davarpanah, Rene Costello +12 more

SWOG S1314: A randomized phase II study of co-expression extrapolation (COXEN) with neoadjuvant chemotherapy for localized, muscle-invasive bladder cancer with overall survival follow up.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.536

N/A

0DataRank · unranked

5 citations

Catherine M. Tangen, Siamak Daneshmand, Ajjai Alva, M. Scott Lucia, David J. McConkey +12 more

Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0602

N/A

0DataRank · unranked

19 citations

David J. McConkey, Catherine M. Tangen, Joshua J. Meeks, Thomas W. Flaig, Xing Hua +12 more

Vinblastine pharmacokinetics in mouse, dog, and human in the context of a physiologically based model incorporating tissue‐specific drug binding, transport, and metabolism

Pharmacology Research & Perspectives(2023)10.1002/prp2.1052

N/A

0DataRank · unranked

12 citations

Keagan P. Collins, Dominique Ramirez, Joshua Mannheimer, Luke A. Wittenburg, Daniel L. Gustafson +1 more

EYA2 tyrosine phosphatase inhibition reduces MYC and prevents medulloblastoma progression

Neuro-Oncology(2023)10.1093/neuonc/noad128

N/A

0DataRank · unranked

11 citations

Melanie Y. Vincent, Taylor Hotz, Stephen C. Purdy, Sheera R. Rosenbaum, Connor J. Hughes +17 more

Data from Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs

(2023)10.1158/1078-0432.c.6529898

N/A

0DataRank · unranked

0 citations

Christina Mazcko, Aswini Cherukuri, Erika P. Berger, William C. Kisseberth, Megan E. Brown +39 more

Data from Pharmacokinetic-directed dosing of vandetanib and docetaxel in a mouse model of human squamous cell carcinoma

(2023)10.1158/1535-7163.c.6531705.v1

N/A

0DataRank · unranked

0 citations

Courtney A. Steinhauer, David Raben, Daniel L. Gustafson, Erica L. Bradshaw‐Pierce

Data from Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs

(2023)10.1158/1078-0432.c.6529898.v1

N/A

0DataRank · unranked

0 citations

Christina Mazcko, Aswini Cherukuri, Erika P. Berger, William C. Kisseberth, Megan E. Brown +39 more

Data from Pharmacokinetic-directed dosing of vandetanib and docetaxel in a mouse model of human squamous cell carcinoma

(2023)10.1158/1535-7163.c.6531705

N/A

0DataRank · unranked

0 citations

Courtney A. Steinhauer, David Raben, Daniel L. Gustafson, Erica L. Bradshaw‐Pierce

First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-20-0106

N/A

0DataRank · unranked

29 citations

Qiong Zhou, Hector Esquer, Laura A. Pike, Travis P. Broneske, Sébastien Rinaldetti +10 more

Lysosomal Biogenesis and Implications for Hydroxychloroquine Disposition

Journal of Pharmacology and Experimental Therapeutics(2020)10.1124/jpet.120.000309

N/A

0DataRank · unranked

29 citations

Sandra Witta, Jonathan Coy, Yi Pang, Daniel L. Gustafson, Keagan P. Collins